Evaluating the PrEP cascade in HIV-negative pregnant and breastfeeding women in South Africa (PrEP-PP)
评估南非 HIV 阴性孕妇和哺乳期妇女的 PrEP 级联 (PrEP-PP)
基本信息
- 批准号:10436266
- 负责人:
- 金额:$ 47.03万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-15 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:AdherenceAdverse eventAfricaAgeAwarenessBehavioralBreast FeedingCellsCohort StudiesCommunicationCommunitiesCounselingCountryDataDiseaseEnsureFamilyFemaleFemale AdolescentsFutureGenitalGenitaliaGovernmentGuidelinesHIVHIV InfectionsHIV SeronegativityHIV-1HealthHealth ServicesHealth care facilityHormonal ChangeIncidenceIndividualInfectionInterventionKnowledgeLettersMeta-AnalysisMethodsModelingMother-to-child HIV transmissionMucous MembraneMultiple PartnersNeonatalOutcomeParticipantPatientsPerinatalPerinatal transmissionPopulationPopulations at RiskPostpartum PeriodPostpartum WomenPredispositionPregnancyPregnant WomenPreventionPrimary Health CareProviderRiskSex BehaviorSouth AfricaSouth AfricanSurfaceTenofovirTimeUnsafe SexVertical Disease TransmissionWomanantiretroviral therapycohorteffective interventionhigh riskmathematical modelpediatric human immunodeficiency virus infectionperinatal HIVpillpre-exposure prophylaxispregnantpreventprogramsprovider factorsrisk perceptionscale upseroconversionside effectsocial stigmasubstance usetransmission processyoung woman
项目摘要
Project Summary/Abstract
HIV-negative pregnant and breastfeeding women in South Africa are at extremely high risk of HIV
acquisition despite increased access to and initiation of antiretroviral therapy (ART) in South Africa. We
urgently need effective interventions to reduce HIV incidence in pregnant and breastfeeding women.
Currently PrEP is one of the only female controlled methods that is effective for preventing HIV acquisition.
PrEP-PP is a study of pre-exposure prophylaxis (PrEP) among HIV-1 seronegative Pregnant and Postpartum
women in two South African urban primary health care facilities. Effective use of PrEP could contribute to
eliminating maternal HIV acquisition, and hence eliminating mother to child HIV transmission (MTCT).
However, PrEP efficacy requires adherence during periods of sexual activity and adherence requires PrEP
access, awareness and counseling. Currently, a major obstacle in the field is the lack of knowledge of women's
initiation, retention and adherence to PrEP during pregnancy and breastfeeding periods in Africa. Now is the
time to evaluate how best to provide PrEP to vulnerable pregnant and breastfeeding women as WHO
recently developed guidelines for providing PrEP in pregnancy and breastfeeding women but there are limited
data on acceptability, initiation and adherence in pregnant and breastfeeding women in Africa where the burden
of HIV is greatest. Our study will focus on the following specific aims:
1. Determine the distribution of women across the PrEP cascade (initiation, retention, and adherence) and
outcomes (HIV acquisition, transmission, and adverse events) in a cohort of pregnant and breastfeeding
women in Cape Town, South Africa
2. Evaluate patient and provider-level factors associated with the PrEP cascade (initiation, retention and
adherence) using quantitative and qualitative approaches
3. Apply an established mathematical model to simulate the impact of improvement in the PrEP cascade on
HIV infections averted (maternal and perinatal)
Our PrEP-PP study is urgent and essential to understand the PrEP cascade in pregnant and
breastfeeding women in South Africa and to identify factors associated with PrEP initiation and adherence to
develop interventions to ensure that everyone in this at-risk population can benefit from PrEP. The results from
the PrEP-PP study will provide a model for the South African Government, and other Governments in the region,
to scale up PrEP delivery among pregnant and breastfeeding women at risk of HIV acquisition and perinatal
transmission and contribute to the elimination of perinatal HIV transmission.
项目摘要/摘要
南非的HIV阴性怀孕和母乳喂养妇女的艾滋病毒风险极高
尽管在南非获得了抗逆转录病毒疗法(ART)的访问和启动,但获得了收购。我们
紧急需要有效的干预措施来减少孕妇和母乳喂养妇女的艾滋病毒发病率。
目前,PREP是唯一有效预防艾滋病毒收购的女性受控方法之一。
PREP-PP是HIV-1血清神经孕妇和产后的暴露前预防(PREP)的研究
南非两个城市初级卫生保健机构的妇女。有效使用准备可能有助于
消除孕产妇的艾滋病毒获取,从而消除母亲的艾滋病毒传播(MTCT)。
但是,准备疗效需要在性活动和遵守期间遵守性
访问,意识和咨询。目前,该领域的主要障碍是缺乏对妇女的了解
在非洲怀孕和母乳喂养期间的启动,保留和依从性。现在是
是时候评估如何最好地为脆弱的怀孕和母乳喂养的妇女做好准备
最近制定了提供怀孕和母乳喂养妇女准备的准则,但有限
关于非洲怀孕和母乳喂养妇女的可接受性,起始和依从性的数据
艾滋病毒是最伟大的。我们的研究将侧重于以下具体目标:
1。确定妇女在整个级联级联的分布(启动,保留和依从性)和
在孕妇和母乳喂养的队列中的结果(HIV获取,传播和不良事件)
南非开普敦的妇女
2。评估与准备级联相关的患者和提供者级别的因素(启动,保留和
使用定量和定性方法的依从性)
3。应用已建立的数学模型来模拟准备级联对改进的影响
避免HIV感染(孕产妇和围产期)
我们的PREP-PP研究迫切且至关重要,对于理解怀孕和
南非的母乳喂养妇女,并确定与准备和遵守有关的因素
制定干预措施以确保这种高危人群中的每个人都可以从准备中受益。结果
PreP-PP研究将为南非政府和该地区的其他政府提供模型,
扩大怀孕和母乳喂养的妇女的准备,有艾滋病毒和围产期的风险
传播并有助于消除围产期艾滋病毒的传播。
项目成果
期刊论文数量(20)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Psychosocial determinants of pre-exposure prophylaxis use among pregnant adolescent girls and young women in Cape Town, South Africa: A qualitative study.
南非开普敦怀孕少女和年轻妇女暴露前预防使用的心理社会决定因素:一项定性研究。
- DOI:10.1177/09564624231152776
- 发表时间:2023
- 期刊:
- 影响因子:1.4
- 作者:Haribhai,Sonia;Khadka,Nehaa;Mvududu,Rufaro;Mashele,Nyiko;Bekker,Linda-Gail;Gorbach,Pamina;Coates,ThomasJ;Myer,Landon;JosephDavey,DvoraLeah
- 通讯作者:JosephDavey,DvoraLeah
"I had Made the Decision, and No One was Going to Stop Me" -Facilitators of PrEP Adherence During Pregnancy and Postpartum in Cape Town, South Africa.
- DOI:10.1007/s10461-021-03320-x
- 发表时间:2021-12
- 期刊:
- 影响因子:4.4
- 作者:Joseph Davey DL;Knight L;Markt-Maloney J;Tsawe N;Gomba Y;Mashele N;Dovel K;Gorbach P;Bekker LG;Coates TJ;Myer L
- 通讯作者:Myer L
Maternal PrEP Use in HIV-Uninfected Pregnant Women in South Africa: Role of Stigma in PrEP Initiation, Retention and Adherence.
- DOI:10.1007/s10461-021-03374-x
- 发表时间:2022-01
- 期刊:
- 影响因子:4.4
- 作者:Moran A;Mashele N;Mvududu R;Gorbach P;Bekker LG;Coates TJ;Myer L;Joseph Davey D
- 通讯作者:Joseph Davey D
Urgent appeal to implement pre-exposure prophylaxis for pregnant and breastfeeding women in South Africa.
紧急呼吁对南非孕妇和哺乳期妇女实施暴露前预防。
- DOI:
- 发表时间:2021
- 期刊:
- 影响因子:0
- 作者:JosephDavey,DL;Davies,N;Raphael,Y;Pillay,Y;Bekker,L-G
- 通讯作者:Bekker,L-G
Evaluating the use of oral pre-exposure prophylaxis among pregnant and postpartum adolescent girls and young women in Cape Town, South Africa.
- DOI:10.3389/frph.2023.1224474
- 发表时间:2023
- 期刊:
- 影响因子:0
- 作者:Khadka, Nehaa;Gorbach, Pamina M;Nyemba, Dorothy C;Mvududu, Rufaro;Mashele, Nyiko;Javanbakht, Marjan;Nianogo, Roch A;Aldrovandi, Grace M;Bekker, Linda-Gail;Coates, Thomas J;Myer, Landon;Joseph Davey, Dvora L
- 通讯作者:Joseph Davey, Dvora L
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DVORA JOSEPH DAVEY其他文献
DVORA JOSEPH DAVEY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DVORA JOSEPH DAVEY', 18)}}的其他基金
Stepped care to optimize PrEP effectiveness in pregnant and postpartum women (SCOPE-PP) in South Africa
南非孕妇和产后妇女采用阶梯式护理优化 PrEP 效果 (SCOPE-PP)
- 批准号:
10663362 - 财政年份:2021
- 资助金额:
$ 47.03万 - 项目类别:
Stepped care to optimize PrEP effectiveness in pregnant and postpartum women (SCOPE-PP) in South Africa
南非孕妇和产后妇女采用阶梯式护理优化 PrEP 效果 (SCOPE-PP)
- 批准号:
10326755 - 财政年份:2021
- 资助金额:
$ 47.03万 - 项目类别:
Stepped care to optimize PrEP effectiveness in pregnant and postpartum women (SCOPE-PP) in South Africa
南非孕妇和产后妇女采用阶梯式护理优化 PrEP 效果 (SCOPE-PP)
- 批准号:
10491149 - 财政年份:2021
- 资助金额:
$ 47.03万 - 项目类别:
Evaluation of pre-exposure prophylaxis cascade in pregnant and breastfeeding women in Cape Town, South Africa
南非开普敦孕妇和哺乳期妇女的暴露前预防级联评估
- 批准号:
9789716 - 财政年份:2018
- 资助金额:
$ 47.03万 - 项目类别:
Evaluation of pre-exposure prophylaxis cascade in pregnant and breastfeeding women in Cape Town, South Africa
南非开普敦孕妇和哺乳期妇女的暴露前预防级联评估
- 批准号:
10330557 - 财政年份:2018
- 资助金额:
$ 47.03万 - 项目类别:
Evaluation of pre-exposure prophylaxis cascade in pregnant and breastfeeding women in Cape Town, South Africa
南非开普敦孕妇和哺乳期妇女的暴露前预防级联评估
- 批准号:
10084331 - 财政年份:2018
- 资助金额:
$ 47.03万 - 项目类别:
Evaluating the PrEP cascade in HIV-negative pregnant and breastfeeding women in South Africa (PrEP-PP)
评估南非 HIV 阴性孕妇和哺乳期妇女的 PrEP 级联 (PrEP-PP)
- 批准号:
10222525 - 财政年份:2018
- 资助金额:
$ 47.03万 - 项目类别:
相似海外基金
Self-management Intervention for Reducing Epilepsy Burden among Ugandans with Epilepsy
减轻乌干达癫痫患者癫痫负担的自我管理干预措施
- 批准号:
10740917 - 财政年份:2023
- 资助金额:
$ 47.03万 - 项目类别:
Community-based Medication Adherence Support for Older Adults Living with HIV and Hypertension (CBA Intervention)
为感染艾滋病毒和高血压的老年人提供基于社区的药物依从性支持(CBA 干预)
- 批准号:
10752723 - 财政年份:2023
- 资助金额:
$ 47.03万 - 项目类别:
Project 1 - Surveillance and monitoring systems to identify strategies to improve perinatal practices [Parent Title: PREVENTING INFANT INFECTIONS WITH IMPLEMENTATION SCIENCE IN MALAWI]
项目 1 - 监测和监测系统,以确定改善围产期实践的策略[父标题:马拉维通过实施科学预防婴儿感染]
- 批准号:
10701195 - 财政年份:2023
- 资助金额:
$ 47.03万 - 项目类别:
The Bring BPaL2Me Trial - Comparing Nurse-Led RR-TB Treatment in Primary Care to Physician-Led, Hospital-Based RR-TB Treatment: A Cluster Randomized, Non-Inferiority Trial
Bring BPaL2Me 试验 - 比较初级保健中护士主导的 RR-TB 治疗与医生主导、医院为基础的 RR-TB 治疗:整群随机、非劣效性试验
- 批准号:
10698492 - 财政年份:2023
- 资助金额:
$ 47.03万 - 项目类别:
PRESCIENT: A phase IIc, open-label, randomized controlled trial of ultra-short course bedaquiline, clofazimine, pyrazinamide and delamanid versus standard therapy for drug-susceptible tuberculosis
PRESCIENT:一项针对药物敏感结核病的超短疗程贝达喹啉、氯法齐明、吡嗪酰胺和德拉马尼与标准疗法的 IIc 期、开放标签、随机对照试验
- 批准号:
10488329 - 财政年份:2022
- 资助金额:
$ 47.03万 - 项目类别: